Decibel Therapeutics Inc (DBTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Operating Expenses | 13,007 | 7,088 | 7,854 | 11,614 | 0 |
| Operating Income | -13,007 | -7,088 | -7,854 | -11,614 | N/A |
| Other Income | 123 | -23 | 47 | 79 | 0 |
| Pre-tax Income | -12,884 | -7,111 | -7,807 | -11,535 | 0 |
| Net Income Continuous | -12,884 | -7,111 | -7,807 | -11,535 | N/A |
| Net Income | $-12,884 | $-7,111 | $-7,807 | $-11,535 | $N/A |
| EPS Basic Total Ops | 89.45 | -20.28 | -22.49 | -31.84 | N/A |
| EPS Basic Continuous Ops | -25.56 | -14.57 | -16.65 | -25.69 | N/A |
| EPS Diluted Total Ops | 54.96 | -20.28 | -22.49 | -31.84 | N/A |
| EPS Diluted Continuous Ops | 35.01 | -14.57 | -16.65 | -25.69 | N/A |
| EBITDA(a) | $-12,662 | $-6,694 | $-7,438 | $-11,127 | $N/A |